{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:00:09Z","timestamp":1785859209039,"version":"3.56.0"},"reference-count":73,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The decline in estrogen levels in postmenopausal women is a major risk factor for the high prevalence of osteoporosis and vascular calcification in this population. Estrogen deficiency leads to an imbalance in the RANKL\/OPG ratio, abnormalities in the Wnt\/\u03b2-catenin pathway, and disruptions in bone morphogenetic protein (BMP) signaling, thereby inducing osteoporosis and vascular calcification. Moreover, estrogen deficiency affects calcium and phosphorus metabolism and induces the release of extracellular vesicles from the aging bone matrix, which mediate interactions between bone and vascular tissues and promote the occurrence of the \"calcification paradox.\" The epigenetic regulation of estrogen receptors, including DNA methylation, histone modification, and miRNA activity, exerts different effects in bone and vascular tissues, underscoring the complexity of estrogen regulation. Future research should focus on the precise regulation of estrogen receptor subtypes and tissue-specific epigenetic modulation mechanisms to develop effective therapeutic strategies for osteoporosis and vascular calcification in postmenopausal women.<\/jats:p>","DOI":"10.1515\/jtim-2026-0026","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:52:08Z","timestamp":1775562728000},"page":"192-203","source":"Crossref","is-referenced-by-count":3,"title":["Postmenopausal osteoporosis and vascular calcification: The estrogen regulation network and calcification paradox"],"prefix":"10.1515","volume":"14","author":[{"given":"Yanxia","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Geriatrics, The First Hospital of China Medical University , Shenyang , Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The First Hospital of China Medical University , Shenyang , Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of China Medical University , Shenyang , Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-6350","authenticated-orcid":false,"given":"Wen","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The First Hospital of China Medical University , Shenyang , Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"2026042612202581650_j_jtim-2026-0026_ref_001","doi-asserted-by":"crossref","unstructured":"Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, et al. The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey. J Bone Miner Res 2019;34:1789\u20131797.","DOI":"10.1002\/jbmr.3757"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_002","doi-asserted-by":"crossref","unstructured":"Emmanuelle NE, Marie-C\u00e9cile V, Florence T, Jean-Fran\u00e7ois A, Fran\u00e7oise L, Coralie F, et al. Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications. Int J Mol Sci 2021;22:1568.","DOI":"10.3390\/ijms22041568"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_003","doi-asserted-by":"crossref","unstructured":"Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591\u20132602.","DOI":"10.1056\/NEJMoa071513"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_004","doi-asserted-by":"crossref","unstructured":"Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 2010;107:466\u2013475.","DOI":"10.1161\/CIRCRESAHA.110.216846"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_005","doi-asserted-by":"crossref","unstructured":"Riggs BL, Melton LJ, 3rd. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620\u2013627.","DOI":"10.1056\/NEJM199208273270908"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_006","doi-asserted-by":"crossref","unstructured":"Lee AW, Wu AH, Wiensch A, Mukherjee B, Terry KL, Harris HR, et al. Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored. Epidemiology 2020;31:402\u2013408.","DOI":"10.1097\/EDE.0000000000001175"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_007","doi-asserted-by":"crossref","unstructured":"Arterburn JB, Prossnitz ER. G Protein-Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications. Annu Rev Pharmacol Toxicol 2023;63:295\u2013320.","DOI":"10.1146\/annurev-pharmtox-031122-121944"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_008","doi-asserted-by":"crossref","unstructured":"Jia M, Dahlman-Wright K, Gustafsson J. Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab 2015;29:557\u2013568.","DOI":"10.1016\/j.beem.2015.04.008"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_009","doi-asserted-by":"crossref","unstructured":"Paterni I, Granchi C, Katzenellenbogen JA, Minutolo F. Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): subtype-selective ligands and clinical potential. Steroids 2014;90:13\u201329.","DOI":"10.1016\/j.steroids.2014.06.012"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_010","doi-asserted-by":"crossref","unstructured":"McRobb LS, McGrath KCY, Tsatralis T, Liong EC, Tan JTM, Hughes G, et al. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation. Arterioscler Thromb Vasc Biol 2017;37:1127\u20131137.","DOI":"10.1161\/ATVBAHA.117.309054"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_011","doi-asserted-by":"crossref","unstructured":"Prossnitz ER, Barton M. The G protein-coupled oestrogen receptor GPER in health and disease: an update. Nat Rev Endocrinol 2023;19:407\u2013424.","DOI":"10.1038\/s41574-023-00822-7"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_012","doi-asserted-by":"crossref","unstructured":"Diaz-Zegarra LA, Espejo MS, Iba\u00f1ez AM, Rando ME, Pagola LE, De Giusti VC, et al. Activation of G Protein-Coupled Estrogen Receptor (GPER) Negatively Modulates Cardiac Excitation-Contraction Coupling (ECC) through the PI3K\/NOS\/NO Pathway. Int J Mol Sci 2024;25:8993.","DOI":"10.3390\/ijms25168993"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_013","doi-asserted-by":"crossref","unstructured":"Khan K, Pal S, Yadav M, Maurya R, Trivedi AK, Sanyal S, et al. Prunetin signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteoblasts to promote bone regeneration. J Nutr Biochem 2015;26:1491\u20131501.","DOI":"10.1016\/j.jnutbio.2015.07.021"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_014","doi-asserted-by":"crossref","unstructured":"Chuang SC, Chen CH, Chou YS, Ho ML, Chang JK. G Protein-Coupled Estrogen Receptor Mediates Cell Proliferation through the cAMP\/PKA\/ CREB Pathway in Murine Bone Marrow Mesenchymal Stem Cells. Int J Mol Sci 2020;21:6490.","DOI":"10.3390\/ijms21186490"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_015","doi-asserted-by":"crossref","unstructured":"Dong WH, Chen JC, He YL, Xu JJ, Mei YA. Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. Am J Physiol Cell Physiol 2013;305:C547\u2013557.","DOI":"10.1152\/ajpcell.00146.2013"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_016","doi-asserted-by":"crossref","unstructured":"Altmann JB, Yan G, Meeks JF, Abood ME, Brailoiu E, Brailoiu GC. G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells. J Neurochem 2015;133:629\u2013639.","DOI":"10.1111\/jnc.13066"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_017","doi-asserted-by":"crossref","unstructured":"Zhu D, Li X, Macrae VE, Simoncini T, Fu X. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition. Trends Endocrinol Metab 2018;29:571\u2013580.","DOI":"10.1016\/j.tem.2018.06.001"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_018","doi-asserted-by":"crossref","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell 2006;125:247\u2013260.","DOI":"10.1016\/j.cell.2006.01.051"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_019","doi-asserted-by":"crossref","unstructured":"Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 2006;103:14925\u201314930.","DOI":"10.1073\/pnas.0606805103"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_020","doi-asserted-by":"crossref","unstructured":"Li X, Chen W, Li P, Wei J, Cheng Y, Liu P, et al. Follicular Stimulating Hormone Accelerates Atherogenesis by Increasing Endothelial VCAM-1 Expression. Theranostics 2017;7:4671\u20134688.","DOI":"10.7150\/thno.21216"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_021","doi-asserted-by":"crossref","unstructured":"Julie A Stilley, Rongbin Guan, Diane M Duffy, Deborah L Segaloff. Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis. J Clin Endocrinol Metab 2014;99:E813\u2013820.","DOI":"10.1210\/jc.2013-3186"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_022","doi-asserted-by":"crossref","unstructured":"Liu XM, Chan HC, Ding GL, Cai J, Song Y, Wang TT, et al. FSH regulates fat accumulation and redistribution in aging through the G\u03b1i\/Ca(2+)\/ CREB pathway. Aging Cell 2015;14:409\u2013420.","DOI":"10.1111\/acel.12331"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_023","doi-asserted-by":"crossref","unstructured":"Song Y, Wang ES, Xing LL, Shi S, Qu F, Zhang D, et al. Follicle-Stimulating Hormone Induces Postmenopausal Dyslipidemia Through Inhibiting Hepatic Cholesterol Metabolism. J Clin Endocrinol Metab 2016;101:254\u2013263.","DOI":"10.1210\/jc.2015-2724"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_024","doi-asserted-by":"crossref","unstructured":"Omran A, Atanasova D, Landgren F, Magnusson P. Sclerostin: From Molecule to Clinical Biomarker. Int J Mol Sci 202226;23:4751.","DOI":"10.3390\/ijms23094751"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_025","doi-asserted-by":"crossref","unstructured":"Hsu SH, Chen LR, Chen KH. Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments. Int J Mol Sci 2024;25:12139.","DOI":"10.3390\/ijms252212139"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_026","doi-asserted-by":"crossref","unstructured":"Yeh PS, Chen JT, Cherng YG, Yang ST, Tai YT, Chen RM. Methylpiperidinopyrazole Attenuates Estrogen-Induced Mitochondrial Energy Production and Subsequent Osteoblast Maturation via an Estrogen Receptor Alpha-Dependent Mechanism. Molecules 2020;25:2876.","DOI":"10.3390\/molecules25122876"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_027","doi-asserted-by":"crossref","unstructured":"Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007;130:811\u2013823.","DOI":"10.1016\/j.cell.2007.07.025"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_028","doi-asserted-by":"crossref","unstructured":"Van Abel M, Hoenderop JG, Dardenne O, St Arnaud R, Van Os CH, Van Leeuwen HJ, et al. 1, 25-dihydroxyvitamin D (3)-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J Am Soc Nephrol 2002;13:2102210\u20132102219.","DOI":"10.1097\/01.ASN.0000022423.34922.2A"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_029","doi-asserted-by":"crossref","unstructured":"Bitirim CV, Ozer ZB, Akcali KC. Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells. PeerJ 2021;9:e12071.","DOI":"10.7717\/peerj.12071"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_030","doi-asserted-by":"crossref","unstructured":"Novella S, P\u00e9rez-Cremades D, Mompe\u00f3n A, Hermenegildo C. Mechanisms underlying the influence of oestrogen on cardiovascular physiology in women. J Physiol 2019;597:4873\u20134886.","DOI":"10.1113\/JP278063"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_031","doi-asserted-by":"crossref","unstructured":"Vidal-G\u00f3mez X, P\u00e9rez-Cremades D, Mompe\u00f3n A, Dantas AP, Novella S, Hermenegildo C. MicroRNA as Crucial Regulators of Gene Expression in Estradiol-Treated Human Endothelial Cells. Cell Physiol Biochem 2018;45:1878\u20131892.","DOI":"10.1159\/000487910"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_032","doi-asserted-by":"crossref","unstructured":"Hill BJF, Dalton RJ, Joseph BK, Thakali KM, Rusch NJ. 17\u03b2-estradiol reduces Cav 1.2 channel abundance and attenuates Ca2+ -dependent contractions in coronary arteries. Pharmacol Res Perspect 2017;5:e00358.","DOI":"10.1002\/prp2.358"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_033","doi-asserted-by":"crossref","unstructured":"Ullrich ND, Koschak A, MacLeod KT. Oestrogen directly inhibits the cardiovascular L-type Ca2+ channel Cav1.2. Biochem Biophys Res Com-mun 2007;361:522\u2013527.","DOI":"10.1016\/j.bbrc.2007.07.054"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_034","doi-asserted-by":"crossref","unstructured":"Smirnova NF, Fontaine C, Buscato M, Lupieri A, Vinel A, Valera MC, et al. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells. Circ Res 2015;117:770\u2013778.","DOI":"10.1161\/CIRCRESAHA.115.306416"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_035","doi-asserted-by":"crossref","unstructured":"Sharma RV, Gurjar MV, Bhalla RC. Selected contribution: estrogen receptor-alpha gene transfer inhibits proliferation and NF-kappaB activation in VSM cells from female rats. J Appl Physiol (1985) 2001;91:2400\u20132406.","DOI":"10.1152\/jappl.2001.91.5.2400"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_036","doi-asserted-by":"crossref","unstructured":"Wang H, Liu Y, Zhu L, Wang W, Wan Z, Chen F, et al. 17\u03b2-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor \u03b1-dependent pathway. Int J Mol Med 2014;33:550\u2013558.","DOI":"10.3892\/ijmm.2014.1619"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_037","unstructured":"Bao Z, Liu ZQ, He PY, Adali J, Yang YC, Wulasihan M. 17\u03b2-estradiol regulates adenosine triphosphate-binding cassette transporters A1 expression via estrogen receptor A to increase macrophage cholesterol efflux. J Physiol Pharmacol 2023;74:10."},{"key":"2026042612202581650_j_jtim-2026-0026_ref_038","doi-asserted-by":"crossref","unstructured":"Novella S, Heras M, Hermenegildo C, Dantas AP. Effects of estrogen on vascular inflammation: a matter of timing. Arterioscler Thromb Vasc Biol 2012;32:2035\u20132042.","DOI":"10.1161\/ATVBAHA.112.250308"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_039","doi-asserted-by":"crossref","unstructured":"Jia K, Luo X, Yi J, Zhang C. Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells. Biol Res 2024;57:61.","DOI":"10.1186\/s40659-024-00542-w"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_040","doi-asserted-by":"crossref","unstructured":"Peng YQ, Xiong D, Lin X, Cui RR, Xu F, Zhong JY, et al. Oestrogen Inhibits Arterial Calcification by Promoting Autophagy. Sci Rep 2017;7:3549.","DOI":"10.1038\/s41598-017-03801-x"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_041","doi-asserted-by":"crossref","unstructured":"Zhang ML, Zhang MN, Wang WL, Chen H, Wang X, Li X, et al. 17\u03b2-estradiol reduces NF-\u03baB expression induced by increased crosstalk between KLF5 and ER\u03b1 in murine vascular smooth muscle cells. Biochem Biophys Res Commun 2022;625:181\u2013187.","DOI":"10.1016\/j.bbrc.2022.07.054"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_042","doi-asserted-by":"crossref","unstructured":"Sutton NR, Malhotra R, St Hilaire C, Aikawa E, Blumenthal RS, Gackenbach G, et al. Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification. Arterioscler Thromb Vasc Biol 2023;43:15\u201329.","DOI":"10.1161\/ATVBAHA.122.317332"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_043","doi-asserted-by":"crossref","unstructured":"Nanao-Hamai M, Son BK, Hashizume T, Ogawa S, Akishita M. Protective effects of estrogen against vascular calcification via estrogen receptor \u03b1-dependent growth arrest-specific gene 6 transactivation. Biochem Biophys Res Commun 2016;480:429\u2013435.","DOI":"10.1016\/j.bbrc.2016.10.066"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_044","doi-asserted-by":"crossref","unstructured":"Lu Q, Xiang DX, Yuan HY, Xiao Y, Yuan LQ, Li HB. Puerarin attenuates calcification of vascular smooth muscle cells. Am J Chin Med 2014;42:337\u2013347.","DOI":"10.1142\/S0192415X14500220"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_045","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, et al. Raloxifene and cardiovascular events in osteo-porotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002;287:847\u2013857.","DOI":"10.1001\/jama.287.7.847"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_046","doi-asserted-by":"crossref","unstructured":"Choi BG, Vilahur G, Zafar MU, Cardoso L, Yadegar D, Ibanez B, et al. Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis 2008;201:76\u201384.","DOI":"10.1016\/j.atherosclerosis.2008.01.017"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_047","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125\u2013137.","DOI":"10.1056\/NEJMoa062462"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_048","doi-asserted-by":"crossref","unstructured":"Liedert A, Nemitz C, Haffner-Luntzer M, Schick F, Jakob F, Ignatius A. Effects of Estrogen Receptor and Wnt Signaling Activation on Mechanically Induced Bone Formation in a Mouse Model of Postmenopausal Bone Loss. Int J Mol Sci 2020;21:8301.","DOI":"10.3390\/ijms21218301"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_049","doi-asserted-by":"crossref","unstructured":"Cannata-And\u00eda JB, Carrillo-L\u00f3pez N, Messina OD, Hamdy NAT, Panizo S, Ferrari SL, et al. Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing? Nutrients 2021;13:3835.","DOI":"10.3390\/nu13113835"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_050","doi-asserted-by":"crossref","unstructured":"Chen B, Zhao Y, Han D, Zhao B, Mao Y, Cui ZK, et al. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression. J Mol Cell Cardiol 2019;135:10\u201321.","DOI":"10.1016\/j.yjmcc.2019.07.008"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_051","doi-asserted-by":"crossref","unstructured":"Golledge J, Thanigaimani S. Role of Sclerostin in Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2022;42:e187\u2013e202.","DOI":"10.1161\/ATVBAHA.122.317635"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_052","doi-asserted-by":"crossref","unstructured":"Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL. Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 1998;101:413\u2013422.","DOI":"10.1172\/JCI119880"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_053","doi-asserted-by":"crossref","unstructured":"Erdogan MO, Y\u0131ld\u0131z H, Artan S, Solak M, Ta\u015fc\u0131o\u011flu F, D\u00fcndar U, et al. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women. Osteoporos Int 2011;22:1219\u20131225.","DOI":"10.1007\/s00198-010-1312-4"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_054","doi-asserted-by":"crossref","unstructured":"Lehtim\u00e4ki T, Kunnas TA, Mattila KM, Perola M, Penttil\u00e4 A, Koivula T, et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med (Berl) 2002;80:176\u2013180.","DOI":"10.1007\/s00109-001-0311-5"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_055","doi-asserted-by":"crossref","unstructured":"Wang ZX, Luo ZW, Li FX, Cao J, Rao SS, Liu YW, et al. Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox. Nat Commun 2022;13:1453.","DOI":"10.1038\/s41467-022-29191-x"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_056","doi-asserted-by":"crossref","unstructured":"Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001;21:817\u2013824.","DOI":"10.1161\/01.ATV.21.5.817"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_057","doi-asserted-by":"crossref","unstructured":"Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O\u2019Neill WC. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009;75:617\u2013625.","DOI":"10.1038\/ki.2008.646"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_058","doi-asserted-by":"crossref","unstructured":"Kosaku Nitta, Takashi Akiba, Koichi Suzuki, Keiko Uchida, Ryo-Ichiro Watanabe, Kazuhiro Majima, et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004;44:680\u2013688.","DOI":"10.1016\/S0272-6386(04)00937-0"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_059","doi-asserted-by":"crossref","unstructured":"Iseri K, Watanabe M, Yoshikawa H, Mitsui H, Endo T, Yamamoto Y, et al. Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial. J Bone Miner Res 2019;34:1014\u20131024.","DOI":"10.1002\/jbmr.3676"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_060","doi-asserted-by":"crossref","unstructured":"Cai G, Keen HI, Host LV, Aitken D, Laslett LL, Winzenberg T, et al. Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON Pivotal Fracture Trial. Osteoporos Int 2020;31:1741\u20131747.","DOI":"10.1007\/s00198-020-05430-z"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_061","doi-asserted-by":"crossref","unstructured":"Geers J, Bing R, Pawade TA, Doris MK, Daghem M, Fletcher AJ, et al. Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial. J Am Heart Assoc 2024;13:e032571.","DOI":"10.1161\/JAHA.123.032571"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_062","doi-asserted-by":"crossref","unstructured":"Haihong Lv, Xiaolan Ma, Tuanjie Che, Yirong Chen. Methylation of the promoter A of estrogen receptor alpha gene in hBMSC and osteoblasts and its correlation with homocysteine. Mol Cell Biochem 2011;355:35\u201345.","DOI":"10.1007\/s11010-011-0836-z"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_063","doi-asserted-by":"crossref","unstructured":"Liu Z, Lee HL, Suh JS, Deng P, Lee CR, Bezouglaia O, et al. The ER\u03b1\/KDM6B regulatory axis modulates osteogenic differentiation in human mesenchymal stem cells. Bone Res 2022;10:3.","DOI":"10.1038\/s41413-021-00171-z"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_064","doi-asserted-by":"crossref","unstructured":"Elbaz A, Rivas D, Duque G. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL\/6J mice. Biogerontology 2009;10:747\u2013755.","DOI":"10.1007\/s10522-009-9221-7"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_065","doi-asserted-by":"crossref","unstructured":"Zuo HL, Xin H, Yan XN, Huang J, Zhang YP, Du H. 17\u03b2-Estradiol improves osteoblastic cell function through the Sirt1\/NF-\u03baB\/MMP-8 pathway. Climacteric 2020;23:404\u2013409.","DOI":"10.1080\/13697137.2020.1758057"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_066","doi-asserted-by":"crossref","unstructured":"Zainabadi K, Liu CJ, Guarente L. SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2. PLoS One 2017;12:e0178520.","DOI":"10.1371\/journal.pone.0178520"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_067","doi-asserted-by":"crossref","unstructured":"Hammad SK, Eissa RG, Shaheen MA, Younis NN. Resveratrol Ameliorates Aortic Calcification in Ovariectomized Rats via SIRT1 Signaling. Curr Issues Mol Biol 2021;43:1057\u20131071.","DOI":"10.3390\/cimb43020075"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_068","doi-asserted-by":"crossref","unstructured":"Dong Q, Lu L, Zhang X, Feng L, Li L, Liu H, et al. NAMPT Is A Novel Inhibitor of Vascular Calcification in Chronic Kidney Disease. Arterioscler Thromb Vasc Biol 2025;45:1872\u20131892.","DOI":"10.1161\/ATVBAHA.125.322549"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_069","doi-asserted-by":"crossref","unstructured":"Bendale DS, Karpe PA, Chhabra R, Shete SP, Shah H, Tikoo K. 17-\u03b2 Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1\/AMPK\/H3 acetylation. Br J Pharmacol 2013;170:779\u2013795.","DOI":"10.1111\/bph.12290"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_070","doi-asserted-by":"crossref","unstructured":"Lin C, Yu S, Jin R, Xiao Y, Pan M, Pei F, et al. Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis. Theranostics 2019;9:3780\u20133797.","DOI":"10.7150\/thno.34493"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_071","doi-asserted-by":"crossref","unstructured":"Guo L, Chen K, Yuan J, Huang P, Xu X, Li C, et al. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPAR\u03b3 and APC. J Cell Physiol 2018;234:581\u2013594.","DOI":"10.1002\/jcp.26788"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_072","doi-asserted-by":"crossref","unstructured":"Panizo S, Naves-D\u00edaz M, Carrillo-L\u00f3pez N, Mart\u00ednez-Arias L, Fern\u00e1ndez-Mart\u00edn JL, Ruiz-Torres MP, et al. MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. J Am Soc Nephrol 2016;27:824\u2013834.","DOI":"10.1681\/ASN.2014050520"},{"key":"2026042612202581650_j_jtim-2026-0026_ref_073","doi-asserted-by":"crossref","unstructured":"Wang Q, Peng F, Yang J, Chen X, Peng Z, Zhang M, et al. MicroRNAs regulate the vicious cycle of vascular calcification-osteoporosis in post-menopausal women. Mol Biol Rep 2024;51:622.","DOI":"10.1007\/s11033-024-09550-1"}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0026\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T12:24:00Z","timestamp":1777206240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0026\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,5]]},"published-print":{"date-parts":[[2026,4,21]]}},"alternative-id":["10.1515\/jtim-2026-0026"],"URL":"https:\/\/doi.org\/10.1515\/jtim-2026-0026","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}